WallStreetZenWallStreetZen

NASDAQ: AXSM
Axsome Therapeutics Inc Stock Ownership - Who owns Axsome Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Axsome Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Hunter R. MurdockGeneral Counsel2025-06-236,014$29.91
$179.88kBuy
Hunter R. MurdockGeneral Counsel2025-06-236,014$100.12
$602.12kSell
Hunter R. MurdockGeneral Counsel2025-06-207,500$102.47
$768.53kSell
Hunter R. MurdockGeneral Counsel2025-06-207,500$29.91
$224.33kBuy
Hunter R. MurdockGeneral Counsel2025-06-187,500$29.91
$224.33kBuy
Hunter R. MurdockGeneral Counsel2025-06-187,500$100.90
$756.75kSell
Hunter R. MurdockGeneral Counsel2025-06-177,500$29.91
$224.33kBuy
Hunter R. MurdockGeneral Counsel2025-06-177,500$100.26
$751.95kSell
Hunter R. MurdockGeneral Counsel2025-06-167,500$29.91
$224.33kBuy
Hunter R. MurdockGeneral Counsel2025-06-167,500$102.42
$768.15kSell

1 of 3

AXSM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AXSM insiders and whales buy or sell their stock.

AXSM Shareholders

What type of owners hold Axsome Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Herriot Tabuteau14.73%7,351,729$871.25MInsider
Antecip Capital LLC14.72%7,344,500$870.40MInsider
Vanguard Group Inc7.91%3,945,020$467.52MInstitution
Blackrock Inc7.69%3,834,990$454.48MInstitution
Bvf Inc3.39%1,690,221$200.31MInstitution
Rtw Investments LP3.04%1,516,903$179.77MInstitution
Macquarie Group Ltd2.28%1,137,748$134.83MInstitution
Geode Capital Management LLC1.98%989,453$117.26MInstitution
Fmr LLC1.96%976,730$115.75MInstitution
State Street Corp1.92%958,503$113.59MInstitution

1 of 3

AXSM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AXSM70.55%29.45%Net BuyingNet Selling
RNA88.72%11.28%Net SellingNet Selling
NUVL75.08%24.92%Net SellingNet Selling
LEGN22.92%0.00%
MRUS90.68%9.32%Net BuyingNet Buying
View Top Biotech Stocks

Axsome Therapeutics Stock Ownership FAQ

Who owns Axsome Therapeutics?

Axsome Therapeutics (NASDAQ: AXSM) is owned by 75.80% institutional shareholders, 31.64% Axsome Therapeutics insiders, and 0.00% retail investors. Herriot Tabuteau is the largest individual Axsome Therapeutics shareholder, owning 7.35M shares representing 14.73% of the company. Herriot Tabuteau's Axsome Therapeutics shares are currently valued at $871.25M.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.